A phase I trial of AAD 2004 in healthy volunteers

Trial Profile

A phase I trial of AAD 2004 in healthy volunteers

Phase of Trial: Phase I

Latest Information Update: 18 Oct 2016

At a glance

  • Drugs AAD 2004 (Primary)
  • Indications Alzheimer's disease; Amyotrophic lateral sclerosis; Parkinson's disease
  • Focus Adverse reactions; First in man; Pharmacokinetics
  • Sponsors GNT Pharma
  • Most Recent Events

    • 30 Aug 2010 Treatment has been successfully completed in the first two cohorts, according to a Neurotech Pharmaceuticals media release.
    • 30 Aug 2010 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top